Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Biochemical Pharmacology

• Publication date

  1985-07-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(85)90551-9PMID 4040369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

  1985cited by this paper
• Glutathione-conferred resistance to antineoplastics: approaches toward its reduction.

  1984cited by this paper
• Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

  1984cited by this paper
• Reversal of adriamycin resistance by verapamil in human ovarian cancer.

  1984cited by this paper
• Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.

  1984cited by this paper
• Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

  1983cited by this paper
• Multidrug-resistance phenotype in Chinese hamster ovary cells.

  1983cited by this paper
• Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells

  1982cited by this paper
• [27] Glutathione S-transferases (rat and human)

  1981cited by this paper
• Glutathione S-transferases (rat and human).

  1981cited by this paper
• Cloning of human ovarian cancer cells in soft agar from malignant and peritoneal washings.

  1980cited by this paper
• Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings

  1980cited by this paper
• Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

  1967cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Cytotoxicity assessment of Pt(II) complexes with tridentate organoselenium based ligands against MCF-7 cancer cell line

  2024cites this paper
• Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer.

  2024cites this paper
• Chitosan Nanoparticles Alleviated the Adverse Effects of Sildenafil on the Oxidative Stress Markers and Antioxidant Enzyme Activities in Rats

  2023cites this paper
• Engineering nanomedicine for glutathione depletion-augmented cancer therapy.

  2021cites this paper
• Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction

  2021influential citation
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper
• Particulate Matter (PM2.5) from Biomass Combustion Induces an Anti-Oxidative Response and Cancer Drug Resistance in Human Bronchial Epithelial BEAS-2B Cells

  2020cites this paper
• Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis

  2020cites this paper
• Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine.

  2019cites this paper
• A chemotherapeutic self-sensibilized drug carrier delivering paclitaxel for the enhanced chemotherapy to human breast MDA-MB-231 cells.

  2019cites this paper
• Glutathione system in animal model of solid tumors: From regulation to therapeutic target.

  2018cites this paper
• Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances

  2018cites this paper
• Applications of Raman spectroscopy in cancer diagnosis

  2018cites this paper
• Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling

  2017cites this paper
• Raman micro‐spectroscopy applied to treatment resistant and sensitive human ovarian cancer cells

  2017cites this paper
• Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.

  2017cites this paper
• The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo

  2016cites this paper
• Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance

  2016cites this paper
• Toward a Better Understanding of the Complexity of Cancer Drug Resistance.

  2016cites this paper
• Design, Synthesis, and Biological Features of Platinum(II) Complexes with Rigid Steric Hindrance.

  2016cites this paper
• Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine

  2016cites this paper
• Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.

  2016cites this paper
• Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.

  2016cites this paper
• Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.

  2016cites this paper
• A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High‐Risk Neuroblastoma

  2016cites this paper
• Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells.

  2015cites this paper
• Design, synthesis and biological evaluation of novel sesquiterpene mustards as potential anticancer agents.

  2015cites this paper
• Pilot study of intravenous melphalan combined with continuous infusion L‐S,R‐buthionine sulfoximine for children with recurrent neuroblastoma

  2015cites this paper
• The study of reduced versus oxidized glutathione in cancer cell models employing isotopically labelled standards

  2014cites this paper
• Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.

  2014cites this paper
• Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments.

  2014cites this paper
• Putative Surrogate Biomarkers to Predict Patients with Acquired Platinum Resistance in Ovarian Cancer

  2014cites this paper
• Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen

  2013cites this paper
• Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione

  2013cites this paper
• Identification and characterization of a 66–68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells

  2013cites this paper
• human ovarian cancer cell lines. interstrand cross-links in cisplatin-resistant Increased gene-specific repair of cisplatin

  2013cites this paper
• In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.

  2013cites this paper
• α-Tocopherol mitigates ethanol induced malformations and cell damage in the eye and brain of the chick embryo

  2012cites this paper
• Decursin Mediated Protection on Cisplatin-induced Nephrotoxicity in SD Rats and BDF1 Mice

  2012cites this paper
• S-allyl derivatives of 6-mercaptopurine are highly potent drugs against human B-CLL through synergism between 6-mercaptopurine and allicin.

  2012cites this paper
• Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells

  2012cites this paper
• REACTIONS OF CISPLATIN HYDROLYTES WITH THIOLS 1: REACTION OF cis-[Pt(15NH3)2(H2O)2]2+WITH N-ACETYL-L-CYSTEINE

  2012cites this paper
• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cites this paper
• 111 REACTIONS OF CISPLATIN HYDROLYTES WITH THIOLS 1: REACTION OF cis -[Pt( 15 NH 3 ) 2 (H 2 O) 2 ] 2+ WITH

  2012cites this paper
• Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells

  2012cites this paper
• Cancer Cell Culture

  2011cites this paper
• Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9

  2011cites this paper
• Nitroxides as cancer imaging agents.

  2011cites this paper
• Platinum Complexes for the Treatment of Cancer

  2011cites this paper
• Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.

  2011cites this paper
• Isolation and culture of ovarian cancer cells and cell lines.

  2011cites this paper
• The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis.

  2011cites this paper
• Reactions of cisplatin hydrolytes, cis-[Pt(15NH3)2(H2O) 2]2+, with N-acetyl-L-cysteine

  2010cites this paper
• Mode of cytotoxic action of nephrotoxic agents: oxidative stress and glutathione‐dependent enzyme

  2010cites this paper
• Tc-99 m glutathione scintigraphy in the detection of primary tumor and staging of patients with lung cancer : a preliminary report

  2010cites this paper
• Mechanisms of drug resistance in ovarian cancer

  2010cites this paper
• Glutathione transferase A1-1: catalytic importance of arginine 15.

  2010cites this paper
• Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer.

  2009cites this paper
• Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role

  2009cites this paper
• Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer

  2009cites this paper
• Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug*

  2009cites this paper
• Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1

  2009cites this paper
• Rational design of pyrrolobenzodiazepine derivatives

  2009cites this paper
• Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity

  2009cites this paper
• Increase in intracellular Zn2+ concentration by thimerosal in rat thymocytes: intracellular Zn2+ release induced by oxidative stress.

  2009cites this paper
• Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.

  2009cites this paper
• Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines

  2008cites this paper
• Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo

  2008cites this paper
• Platinum Anticancer Drugs, Chemical Biology of

  2008cites this paper
• Modulation der Zytotoxizität von oxyradikalbildenden Chemothe- rapeutika durch Einflussnahme auf das Glutathion-Reduktions- Oxidations-System mittels Buthioninsulfoxamid und/oder Ethacrynsäure

  2008cites this paper
• Mammalian cytosolic glutathione transferases.

  2008cites this paper
• Glutathione transferase: new model for glutathione activation.

  2008cites this paper
• GSH loss per se does not affect neuroblastoma survival and is not genotoxic.

  2008cites this paper
• Selenium

  2008cites this paper
• Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues

  2008cites this paper
• Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.

  2007cites this paper
• Buthionine sulfoximine inhibits cytopathic effects and apoptosis induced by infection with AIK-HDC strain of measles virus.

  2007cites this paper
• Searching for potential biomarkers of cisplatin resistance in human ovarian cancer using a label‐free LC/MS‐based protein quantification method

  2007cites this paper
• 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.

  2007cites this paper
• in Human Embryonal Carcinoma Cells Vivo in and in Vitro-Diamminedichloroplatinum ( II ) Resistance cis Updated

  2007cites this paper
• Mismatch Repair Status and the Response of Human Cells to Cisplatin

  2007cites this paper
• An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.

  2007cites this paper
• and 16 11 Ovarian Carcinoma Cell Line Segregates with Chromosomes Expression of the Cisplatin Resistance Phenotype in a Human

  2006cites this paper
• - Diamminedichloroplatinum ( II ) cis and Neck Carcinoma Cells Selected for Resistance to Collateral Methotrexate Resistance in Cultured Human Head

  2006cites this paper
• Molecular Cloning and Characterization of the Complementary DNA for the Mr 85,000 Protein Overexpressed in Adriamycin-resistant Human Tumor Cells1

  2006cites this paper
• Its Effect on Melphalan-induced Toxicity in Mice Pharmacokinetics of Buthionine Sulfoximine ( NSC 326231 ) and Updated Version

  2006cites this paper
• Medulloblastoma Xenograft in Athymic Mice Sulfoximine-mediated Glutathione Depletion in a Human Enhanced Melphalan Cytotoxicity following Buthionine Updated

  2006cites this paper
• Flow Cytometric Analysis of DNA Damage and Repair in the Cells Resistant to Alkylating Agents 1

  2006cites this paper
• Characterization of a c/s-Diamrninedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues1

  2006cites this paper
• m-Diamminedichloroplatinurn ( II ) Accumulation in Sensitive and Resistant Human Ovarian Carcinoma Cells 1

  2006cites this paper
• l-Phenylalanine Mustard -Transferase for the Conjugation of Glutathione with S Specificity of Isozymes of Murine Hepatic Glutathione

  2006cites this paper
• Accumulation of c / Â £-Diamminedichloroplatinum ( II ) and Platinum Analogues by Platinum-resistant Murine Leukemia Cells in Vitro 1

  2006cites this paper
• When Just One Sense Is Available, Multisensory Experience Fills in the Blanks

  2006cites this paper
• Maeda in Vitro Multidrug-resistant Chinese Hamster Ovary Cells Low-Molecular-Weight Anticancer Agents on Comparison of the Cytotoxic Effects of the High-and Updated

  2006cites this paper
• Diazene JK-279 induces apoptosis-like cell death in human cervical carcinoma cells.

  2006cites this paper
• Advances in Brief Single Step Selection of as-Diamminedichloroplatinum ( II ) Resistant Mutants from a Human Ovarian Carcinoma Cell Line 1

  2006cites this paper
• Increased Resistance to c / 5-Diamminedichloroplatinum ( II ) in NIH 3 T 3 Cells Transformed by ras Oncogenes 1

  2006cites this paper
• Cisplatin Resistance in Ovarian Cancer Cell Lines Cross-Resistance to Diverse Drugs Is Associated with Primary Updated Version

  2006cites this paper
• Flow Cytometry Analysis of DNA Damage and the Evaluation of Cytotoxicity of Alkylating Agents 1

  2006cites this paper
• Alkylating Agent Resistance among Four Human Melanoma Cell Lines Selected for Levels π-transferaseS Cross-Resistance and Glutathione-Updated Version

  2006cites this paper